HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Congenital peribronchial myofibroblastic tumor: prenatal imaging clues to differentiate from other fetal chest lesions.

Abstract
We present a prenatal case of congenital peribronchial myofibroblastic tumor referred as a congenital pulmonary airway malformation (CPAM) with hydrops and polyhydramnios at 30 weeks' gestational age. US and fetal MRI findings did not fit with the referral diagnosis, raising the possibility of intrinsic lung tumor. Fetal hydrops worsened and the baby was successfully delivered by ex utero intrapartum treatment (EXIT) to resection at 31 weeks' gestational age. To the best of our knowledge, this is a unique case of congenital peribronchial myofibroblastic tumor that underwent comprehensive prenatal evaluation and EXIT procedure with good outcome.
AuthorsMaria A Calvo-Garcia, Foong-Yen Lim, Jerzy Stanek, Constance Bitters, Beth M Kline-Fath
JournalPediatric radiology (Pediatr Radiol) Vol. 44 Issue 4 Pg. 479-83 (Apr 2014) ISSN: 1432-1998 [Electronic] Germany
PMID24169903 (Publication Type: Case Reports, Journal Article)
Topics
  • Diagnosis, Differential
  • Female
  • Fetal Diseases (diagnosis, surgery)
  • Fibrosarcoma (congenital, diagnosis, surgery)
  • Humans
  • Infant, Newborn
  • Lung Neoplasms (congenital, diagnosis, surgery)
  • Magnetic Resonance Imaging
  • Male
  • Pregnancy
  • Pregnancy Outcome
  • Prenatal Diagnosis
  • Ultrasonography, Prenatal
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: